These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8047810)

  • 21. Effect of colchicine on hepatobiliary function in CCl4 treated rats.
    Rao CV; Mehendale HM
    Biochem Pharmacol; 1991 Nov; 42(12):2323-32. PubMed ID: 1764117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
    J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine.
    Ilfeld D; Theodor E; Delpre G; Kuperman O
    Clin Exp Immunol; 1984 Aug; 57(2):438-42. PubMed ID: 6235989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method].
    Benn HP; Schnier C; Bauer E; Seiler KU; Elhöft H; Löffler H
    Z Rheumatol; 1991; 50(1):32-8. PubMed ID: 2058320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclosporine on colchicine partitioning in the rat liver.
    Speeg KV; Maldonado AL
    Cancer Chemother Pharmacol; 1993; 32(6):434-6. PubMed ID: 8258190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary excretion of colchicine in newborn rats.
    Hunter AL; Klaassen CD
    Drug Metab Dispos; 1975; 3(6):530-5. PubMed ID: 1230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.
    Zifroni A; Schaffner F
    Hepatology; 1991 Dec; 14(6):990-3. PubMed ID: 1959887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocytopenia complicating colchicine therapy for primary biliary cirrhosis.
    Finklestein M; Goldman L; Grace ND; Foley M; Randall N
    Gastroenterology; 1987 Dec; 93(6):1231-5. PubMed ID: 3678740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of aluminum in rats. II: Dose-dependent urinary and biliary excretion.
    Xu ZX; Pai SM; Melethil S
    J Pharm Sci; 1991 Oct; 80(10):946-51. PubMed ID: 1784003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatobiliary excretion and enterohepatic circulation of colchicine in rats.
    Chen YJ; Huang SM; Liu CY; Yeh PH; Tsai TH
    Int J Pharm; 2008 Feb; 350(1-2):230-9. PubMed ID: 17931809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.